Metacrine
CEO Neil McDonnell and Chairman Rich Heyman
Country: USA | Funding: $173M (+)
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases. Permanently closed
Metacrine is an emerging biotech company focused on developing best-in-class therapies to benefit patients with liver, gastrointestinal, and metabolic diseases. Permanently closed
